Tonix Pharmaceuticals Holding Corp.TNXP
Health Care · Pharmaceuticals, Biotechnology & Life Sciences · NASDAQ · United States · tonixpharma.com
Tonix Pharmaceuticals is a biopharmaceutical company developing and commercializing therapeutics for central nervous system, immunology and infectious disease indications, including its approved fibromyalgia product and a portfolio of clinical-stage candidates.
Key ratios
FCF / Sales
-543.3%TTM
2025
-787.5%2024
-604.8%2023
-1414.7%
ROA
-46.8%TTM
2025
-35.7%2024
-30.6%2023
-38.9%
ROE
-81.8%TTM
2025
-64.5%2024
-106.1%2023
-74.6%
Revenue growth
196.0%TTM
2025
29.9%2024
29.9%
Track TNXP in your journal
Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.
Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer